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Objective: To evaluate the effect of Cytomodulin-10 (CM-10), a transforming growth factor-beta analogue,
on wound healing by primary intention.
Method: Sixty male albino rats of Charles Foster strain (100–150 g) were used. After intraperitoneal
anesthesia, a cutaneous incised wound (4 cm) was created on the back of each rat, which was closed by
silk stitches and allowed to heal by primary intention. They were equally divided as test and control.
CM-10 was applied to the test wounds daily. At the end of 7, 14 and 21 days of wounding, 10 rats from
each group were sacriﬁced and their wounds were compared. Outcome measures were: 1) breaking force
of wounds, 2) histological assessment of healing and 3) evaluation of angiogenesis. Statistical signiﬁcance
was assessed by Student’s t-test, ANOVA and Bonferroni correction.
Result: There was a signiﬁcant increase in the breaking force (P< 0.001). Histological examination
showed early epithelization, increased collagen deposition and decreased inﬂammatory cellular inﬁltrate
at 1st week in the test group. The treated wounds also demonstrated earlier remodeling. Angiogenesis
score was signiﬁcantly higher in the test wounds at 1st week (40.6 vs. 30.8; P< 0.001), but not in the
subsequent weeks.
Conclusion: Cytomodulin is a strong promoter of wound healing by primary intention. It increases tensile
strength and induces early epithelization. It also promotes increased collagen deposition, early remod-
eling and increased angiogenesis.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Wound healing is a highly complex yet well coordinated process
of restoration of tissue following injury. This requires accelerated
migration of cells in to the injured site, activation of various
signaling mechanisms, angiogenesis, cellular proliferation,
synthesis of extracellular matrix and subsequent tissue remodel-
ing.1 The early inﬂammatory phase of healing, although inherent to
the organism as a natural defense against environmental assault
actually compromises cosmesis. Increased inﬂammation directly
leads to tissue destruction, which subsequently leads to increased
scarring.2 Pure regeneration of tissue during healing is practically
non-existent in postnatal life.3 Despite extensive research in: þ91 542 2368163.
ciates Ltd. Published by Elsevier Ltgrowth factors and cytokines, the complete understanding of the
orchestration of these cytokines in wound healing is yet to be
learned.
The transforming growth factor-b (TGF-b) is a superfamily of
cytokines elaborated mainly by platelets, keratinocytes, and
macrophages during wound healing. It, particularly TGF-b1, is
believed to regulate a wide range of cellular functions including
epithelization, ﬁbroblast migration, collagen synthesis and matu-
ration, and matrix deposition.4,5 For this reason, bioactive peptides
that mimic the effects of TGF-b1 may have a promising role in
wound healing, especially with the advantage of lower cost, stable
shelf life as compared to TGF-b itself, low immunogenic potential
(due to low molecular weight) and ease of administration and
delivery. Cytomodulins (CMs) are a family of such oligopeptides
which have been designed with the beneﬁt of producing low
immune response, improved administration and drug delivery.
Their efﬁcacy to mimic the function of TGF-b1 has been proven ind. All rights reserved.
Table 1
Comparison of breaking force.
Week Mean breaking force in Newton’s Mean difference (95% Conﬁdence interval) t-Value P-value
Control group (n¼ 10 at every week) Treated group (n¼ 10 at every week)
1st 2.18 0.37 3.31 0.62 1.13 (1.61, 0.65) 4.94 0.000*
2nd 4.83 0.63 5.93 0.54 1.10 (1.66, 0.55) 4.19 0.001*
3rd 9.92 1.64 13.77 2.28 3.85 (5.71, 1.98_ 4.33 <0.001*
*Statistically signiﬁcant.
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were CM-1 and CM-2. In the present experimental study we eval-
uated the effects of Cytomodulin-10 (CM-10), a synthetic hex-
apeptide (patented by the ENTAM LLC, California), on wound
healing by primary intention in a murine model.
2. Animals and method
Sixty male albino rats of Charles Foster strain (100–150 g) were
used in the study to evaluate the effect of CM-10 on wound healing
by primary intention. Approval of the institute animal ethics
committee for the study was obtained. The animals were accli-
matized for one week in the animal house of the laboratory and
were fed on rat chow and water ad libitum. They were anesthetized
by intraperitoneal injection of 6% Nembutal sodium solution
(25 mg/kg) as per the University’s protocol. Depilation and topical
antibacterial preparation (70% alcohol) was done on the back of
each rat. A longitudinal (4 cm) full-thickness cutaneous incision
was made by a surgical blade taking care not to incise the pan-
niculus carnosus. The skin incision was immediately closed with
‘000’ interrupted silk stitches. The animals were then returned to
their cages. They were randomized into a treated and a control
group. In the treated group, CM-10 (40 mg/ml) in a suitable cream
base (Curel) was applied topically over the wound (10 mg/cm2)
once a day while the controls received topical application of theFig. 1. (a) Treated group and (b) control group: At the end of 1st week epithelization is com
Also note the inﬂammatory cell inﬁltrate is lesser than that in the control (H&E, 50).base only. They were housed in separate cages and strict watch was
kept on their feeds. At the end of 7th, 14th and 21st days of
wounding, 10 rats from each group were sacriﬁced by intracardiac
injection of an overdose of Nembutal sodium. Their wounds/scars
were evaluated for healing and harvested as skin strips taking care
not to include the panniculus and subcutaneous tissue. These strips
of tissue were bisected; one half was preserved in 10% formalin for
histological analysis and the other half was used for estimation of
breaking force.2.1. Estimation of wound breaking force
Strips of tissue, 2 cm long 1 cm wide containing the scar line
oriented transversely was cut out and used for estimation of wound
breaking force by the gravimetric method.6 The margins were held
tightly by metal clips on opposite ends and the scar line was sub-
jected to progressively increasing force under gravity till the scar
line broke. The breaking force was expressed in Newton’s (1
Newton¼ 1 KgAcceleration due to gravity). The values for each
week were obtained and compared between the groups. Signiﬁ-
cance of difference was assessed by the Student’s t-test. P values
less than 0.05 were taken as signiﬁcant. Signiﬁcance of difference in
the weekly values of breaking force in the treated group was
assessed by the ANOVA and Bonferroni corrections. However due toplete in the treated group and increased scariﬁcation is noted compared to the control.
Fig. 2. (a) Treated group and (b) control group: Increased young collagen deposition in the treated group at the end of 1st week (Reticulin 50).
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of 0.0083 (0.05/6) was taken as signiﬁcant where necessary.
2.2. Histological evaluation
Strips of tissue harvested from the animals (2 cm 1 cm) con-
taining the scars were preserved in 10% formalin. They were pro-
cessed for histological analysis, embedded and sectioned sagitally
(5 m) through the full thickness of the tissue so that the wound line
was presented in the block for evaluation in its entirety from theFig. 3. (a) Treated group and (b) control group: At the end of 2nd week the scar in the treatepithelial surface to the dermis. These were stained with routine
Hematoxylene–Eosin (H&E) and Reticulin. A total of 60 slides
stained with H&E were evaluated under low and high power of
a photomicroscope (Karl Zeiss, Germany) by an expert histologist
blinded to the treatmentmodality. An additional 20 slides, one each
from the treated and control animals at the end of one week,
stained with Reticulin were evaluated for early collagen deposition.
Qualitative assessments were made with respect to 1) epitheliza-
tion, 2) inﬂammation (assessed by inﬂammatory cell inﬁltrate), 3)
collagen deposition (assessed by thickness of scar), and 4)ed group is remodeling and much thinner compared to that in the control (H&E, 50).
Fig. 4. (a) Treated group and (b) control group: At the end of 3rd week, the scar tissue in the treated group is negligible compared to the control group. The collagen deposition
pattern is almost similar to that of the surrounding dermis indicating early remodeling in the treated group (H&E, 50).
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scar compared with that of the surrounding dermis). A quantitative
evaluation of angiogenesis was done by the microscopic angio-
genesis grading system score (MAGS).2.3. Assessment of angiogenesis by the microscopic
angiogenesis grading system score (MAGS)
All histological slides stained with (H&E) were evaluated under
high power (500) ﬁelds for MAG score. A quantitative assessment
was done using the formula Kn (N)þKe (E)þ Kx (X), where Ks’ are
constants and N, E, X are various measurements of angiogenesis:
N¼ number of capillaries per high power ﬁeld, E¼ number of
endothelial cells lining the cross-section of capillary (diameter not
more than 20 m) and X¼ grade of individual endothelial cells based
on regenerative appearance. Avessel was not considered capillary if
it had smooth muscle cells, elastin membrane and more than three
erythrocytes across the lumen. The values of X were graded as
0¼ normal endothelium, 1¼ plump clear nucleus, 2¼ plump clearFig. 5. (a) Treated group and (b) control group: At the end of 1st week treated group shows e
lined capillaries and vascular granulation tissue (H&E, 500).nucleus with prominent nucleolus, 3¼ large hyperchromatic
nucleus, 4¼ bizarre endothelial cells and 5¼mitotic ﬁgures.7 The
values of MAG score for each week were obtained and were
compared between the treated and control groups. Statistical
signiﬁcance was assessed by the Student’s t-test. P values less than
0.05 were taken as signiﬁcant.
3. Results
There was no death during the study period. A total of thirty
wound strips from each group were evaluated for breaking force,
histology and angiogenesis.
3.1. Estimation of breaking force of wounds
After removal of stitches thirty wound strips were harvested
from each group. The mean breaking forces in the treated group
were 2.18 0.37 N, 4.83 0.63 N and 9.921.64 N on the 7th, 14th
and 21st days (of wounding) respectively which were signiﬁcantlyxtensive angiogenesis as evidenced by the presence of multiple plump endothelial cell-
Table 2
Comparison of MAGS score between groups.
Week MAGS score Mean difference (95% Conﬁdence interval) t-Value P-value
Control group (n¼ 10 at every week) Treated group (n¼ 10 at every week)
1st 30.8 4.78 40.6 4.88 9.8 (14.34, 5.26) 4.54 <0.001*
2nd 24.4 3.41 26.2 4.39 1.8 (5.49, þ1.89) 1.02 0.319
3rd 19.6 2.76 18.5 3.57 1.1 (1.89, þ4.09) 0.77 0.450
*Statistically signiﬁcant.
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also found between the weekly observations in the treated group:
a progressive rise of breaking force between 1st week and 2nd
week (Mean difference¼2.62; 95% Conﬁdence interval¼4.22,
1.02; P¼ 0.001), between 1st and 3rd week (Mean differ-
ence¼10.46; 95% Conﬁdence interval¼12.06, 8.86;
P< 0.001) and between 2nd and 3rd week (Mean differ-
ence¼7.84; 95% Conﬁdence interval¼9.44, 6.24; P< 0.001).
The P-value less than 0.0083 (0.05/6¼ 0.0083) was taken as
signiﬁcant due to Bonferroni correction made for P-value due to
presence of six groups.
3.2. Histological assessment
In the 1st week, both H&E and Reticulin stained sections showed
excessive collagen deposition in the scar line (Fig. 1a,b; Fig. 2a,b).
Epithelization was complete in the treated group ahead of the
controls. Evidence of inﬂammatory cell inﬁltrate was seen in the
control scars by the end of 1st week indicating persistence of
inﬂammatory reaction whereas it was almost absent in the treated
group (Fig. 1a,b). The scar line became progressively thinner in the
treated group in subsequent weeks indicating early healing
compared to that of the controls (Fig. 3a,b). The scars in the treated
animals attained architecture close to the surrounding tissue at 3rd
week, an evidence of early tissue remodeling (Fig. 4a,b).
3.3. Assessment of angiogenesis
Histology of wound sections stainedwith H&E and Reticulinwas
assessed under high magniﬁcation (500) for evidence of angio-
genesis by using the MAGS score.7 Abundance of young regener-
ating capillaries was seen in the treated group compared to the
controls only at the end of 1st week (Fig. 5a,b). However, this
difference was not appreciable in the subsequent weeks. The MAGS
score was signiﬁcantly higher in the ﬁrst week in the treated group
(40.6 4.88 vs. 30.8 4.78). At the end of 2nd and 3rd weeks this
difference was not statistically signiﬁcant (Table 2).
4. Discussion
The TGF-b isoforms (b1, b2 and b3) in mammals share a 64–85%
amino acid homology.8 In cutaneous wound models they are
mitogenic for ﬁbroblasts, stimulate deposition of extracellular
matrix proteins, inhibit matrix metalloproteases and take active
part in the cellular differentiation and remodeling.4,7 Though TGF-
b1 is the most potent ﬁbrogenic cytokine acting in a wound, the
differential expression of these three isomers both temporally and
spatially determines the extent of scar formation.9 The differential
stimulation of their receptors also controls the amount of scariﬁ-
cation. A selective stimulation of R-I is proﬁbrotic whereas
a preponderance of R-II favors an antiproliferative response and
produces a poor scar.10,11 The activation of R-I leads to intracellular
signaling and gene expression. Previous research by one of the
authors indicates that CM produces increased collagen synthesis,due to collagen gene transcription an action similar to that of
TGF-b1 in promoting collagen synthesis.5,12
CM-10 is a synthetic hexapeptide (Leu-Ile-Ala-Asn-Ala-Lys)
with potent proﬁbrotic activity. Research has shown it is active in
nanomolar or micromolar concentration, and in vivo doses can be
as low as nanograms.5 It can be delivered in numerous ways, as
solution, ointments and wound coverings, as part of polymeric
devices, and hydrogels and microspheres thus making it a versatile
adjunct to wound healing. Previous experiments with Cytomodu-
lin-1 and 2 have shown that topical application or injections
signiﬁcantly increased collagen synthesis and gene expression, and
increased wound strength both in vivo and in vitro.5 The present
study shows CM-10 is a potent promoter of wound healing at a very
low dose. It increases breaking force in wounds healed by primary
intention. Early and increased deposition of collagen in the scar is
likely to be responsible for this increased strength indicating CM-10
is a strong stimulus for collagen synthesis. Of interest was the rapid
increase in wound strength in the second week onward. It is
probably due to early tissue remodeling induced by CM-10 as
observed in the histological picture. The remodeled scar tissuewith
collagen ﬁbers aligned in the lines of strain is signiﬁcantly stronger
to withstand higher breaking force.
The histological picture indicates early epithelization in the
treated group and decreased inﬂammatory response by the end of
ﬁrst week. In the subsequent weeks, the scar thickness reduced at
a faster pace in the treated group indicating remodeling.
Angiogenesis is an important marker of healing and measure-
ment of angiogenesis quantitatively assesses healing response.
Evaluation of angiogenesis in the present study showed a signiﬁ-
cantly higher MAG score in the treated group at ﬁrst week. This
difference was not seen in the subsequent weeks, which may be
explained by the fact that in a wound stimulated by CM-10,
angiogenesis appears early and is ﬂorid aiding in early healing.
The present study however does not show the time taken by the
breaking force to plateau in treated scars, for which a study of
longer duration is required. It is also not possible to comment on
the optimal duration of topical application of CM-10 to achieve
signiﬁcantly improved results i.e. whether a single application is as
good as daily application. Since CM-10 is a potent analogue of TGF-
b1, the amount of early collagen deposition is not without expec-
tation. Though collagen deposition is increased, faster remodeling
reduces scarring in a more dynamic way. That CM-10 does reduce
inﬂammation in early stages of wound healing is evident from the
wound histology in the present study, although the exact mecha-
nism of reduced inﬂammatory response is not known. It is also not
yet clear whether CM-10 can inhibit/overcome the pro-inﬂamma-
tory role of TNF-a, a potent inhibitor of TGF-b/Smad signaling,13,14
and promote proliferation. Though it is an attractive hypothesis,
more research is required to substantiate it at the cellular level.
In conclusion, Cytomodulin-10 is a strong promoter of wound
healing by primary intention. It induces early epithelization and
early angiogenesis in the healing wound. Topical application also
results in increased collagen deposition and early remodeling of the
wound leading to increased tensile strength. In future, it may have
potentially useful clinical applications.
S. Basu et al. / International Journal of Surgery 7 (2009) 460–465 465Conﬂict of interest
None declared.
Funding
Departmental research grant.
Ethical approval
Ethical approval was given by the Institute Animal Ethics
Committee vide letter no. Dean/2006-2007/Animal Ethical
Committee/1423. The Ethical committees are under the chair-
manship of the Dean of Institute of Medical Sciences, Banaras
Hindu University.
References
1. Roberts AB, Sporn MB. Transforming growth factor-b. In: Clark RAF, editor. The
molecular and cellular biology of wound repair. 2nd ed. New York: Plenum; 1996.
p. 275–308.
2. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, et al. Connective
tissue growth factor gene expression in tissue sections from localized sclero-
derma, keloid, and other ﬁbrotic skin disorders. J Invest Dermatol 1996;
106:729–33.
3. Cowin AJ, Brosnan MP, Holmes TM, Ferguson MW. Endogenous inﬂammatory
response to dermal wound healing in the fetal and adult mouse. Dev Dyn
1998;212:385–93.
4. Border WA, Noble NA. Transforming growth factor b in tissue ﬁbrosis. N Engl
J Med 1994;331:1286–92.5. Lam HJ, Li S, Lou N, Chu J, Bhatnagar RS. Synthetic peptides cytomodulin-1 and
cytomodulin-2 promote collagen synthesis and wound healing in vitro. In:
Proceedings of the 26th annual international conference of the IEEE EMBS, San
Francisco, CA, USA; 2004;September 1–5. p. 5028–30.
6. Subba Rao BG. Biological phenomena within a pyramid model – a preliminary
study on wound healing. Indian J Physiol Pharmacol 1997;41:57–61.
7. Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for
histologic grading. J Natl Cancer Inst 1972;48:347–56.
8. Frank S, Madlener M, Werner S. Transforming growth factors b1, b2, b3 and
their receptors are differentially regulated during normal and impaired wound
healing. J Biol Chem 1996;271:10188–93.
9. Shah M, Revis D, Herrick S, Baillie R, Thorgeirson S, Fergusson M, et al. Role of
elevated plasma transforming growth factor b1 levels in wound healing. Am
J Pathol 1999;154:1115–24.
10. Chen RH, Ebner R, Derynk R. Inactivation of type II receptor reveals two
receptor pathways for the diverse TGF-b activities. Science 1993;260:
1335–8.
11. McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM, et al.
Decreased type II/type I TGF-beta receptor ratio in cells derived from human
atherosclerotic lesions. Conversion from an antiproliferative to proﬁbrotic
response to TGF-b 1. J Clin Invest 1995;96:2667–75.
12. Bhatnagar RS, Qian JJ, inventors. The Regents of the University of California,
assignee. Peptide composition with growth factor-like activity. United States
patent US5661127; 1997 Aug 26 [unpublished material].
13. Yamane K, Ihn H, Asano Y, Jinnin M, Tamaki K. Antagonistic effects of TNF-alpha
on TGF-beta signaling through downregulation of TGF-beta receptor type II in
human ﬁbroblasts. J Immunol 2003;171:3855–62.
14. Verrecchia F, Pessah M, Atﬁ A, Mauviel A. Tumor necrosis factor-alpha inhibits
transforming growth factor-beta/Smad signaling in human dermal ﬁbroblasts
via AP-1 activation. J Biol Chem 2000;275:30226–31.
